- Home
- OGI vs RGC Comparison
OGI vs RGC Comparison
Compare OGI & RGC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OGI
- RGC
- Stock Information
- Founded
- OGI 2013
- RGC 2014
- Country
- OGI Canada
- RGC Hong Kong
- Employees
- OGI N/A
- RGC N/A
- Industry
- OGI Biotechnology: Pharmaceutical Preparations
- RGC Medicinal Chemicals and Botanical Products
- Sector
- OGI Health Care
- RGC Health Care
- Exchange
- OGI Nasdaq
- RGC Nasdaq
- Market Cap
- OGI 200.6M
- RGC 105.3M
- IPO Year
- OGI N/A
- RGC 2021
- Fundamental
- Price
- OGI $1.55
- RGC $4.86
- Analyst Decision
- OGI
- RGC
- Analyst Count
- OGI 0
- RGC 0
- Target Price
- OGI N/A
- RGC N/A
- AVG Volume (30 Days)
- OGI 820.8K
- RGC 8.8K
- Earning Date
- OGI 02-11-2025
- RGC 10-25-2024
- Dividend Yield
- OGI N/A
- RGC N/A
- EPS Growth
- OGI N/A
- RGC N/A
- EPS
- OGI N/A
- RGC N/A
- Revenue
- OGI $118,317,480.00
- RGC N/A
- Revenue This Year
- OGI $57.65
- RGC N/A
- Revenue Next Year
- OGI $10.93
- RGC N/A
- P/E Ratio
- OGI N/A
- RGC N/A
- Revenue Growth
- OGI 0.69
- RGC N/A
- 52 Week Low
- OGI $1.31
- RGC $3.03
- 52 Week High
- OGI $2.91
- RGC $32.44
- Technical
- Relative Strength Index (RSI)
- OGI 44.32
- RGC 44.96
- Support Level
- OGI $1.56
- RGC $4.75
- Resistance Level
- OGI $1.77
- RGC $5.21
- Average True Range (ATR)
- OGI 0.08
- RGC 0.30
- MACD
- OGI -0.00
- RGC 0.04
- Stochastic Oscillator
- OGI 11.11
- RGC 23.87
About OGI Organigram Holdings Inc.
OrganiGram Holdings Inc is engaged in producing indoor-grown cannabis for patients and adult recreational consumers in Canada. The company has also developed a portfolio of adult-use recreational cannabis brands including Edison, Big Bag o' Buds, SHRED, Monjour, Holy Mountain, and Trailblazer. Tremblant Cannabis, and artisanal craft brand, Laurentian are recent additions to Organigram's existing brand portfolio.
About RGC Regencell Bioscience Holdings Limited
Regencell Bioscience Holdings Ltd is a bioscience company focusing on the research, development, and commercialization of TCM for the treatment of neurocognitive disorders and degenerations, specifically ADHD and ASD, and infectious diseases affecting people's immune systems.